Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Rupert Bauersachs"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 532-549 (2020)
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 532-549 (2020)
Cancer‐associated venous thromboembolism (VTE) is a frequent, potentially life‐threatening event that complicates cancer management. Anticoagulants are the cornerstone of therapy for the treatment and prevention of cancer‐associated thrombosis
Autor:
Manuel Monreal, Cecilia Becattini, Rupert Bauersachs, Marianne Brodmann, Joseph Emmerich, Victor Aboyans, Adriano Alatri, Walter Ageno, Saskia Middeldorp, Marc Philip Righini, Lucia Mazzolai, Stavros Konstantinides, Guy Meyer
Publikováno v:
European Journal of Preventive Cardiology, 29, 8, pp. 1248-1263
European Journal of Preventive Cardiology, 29, 1248-1263
European journal of preventive cardiology, 29(8), 1248-1263. SAGE Publications Ltd
European Journal of Preventive Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European Journal of Preventive Cardiology, 29, 1248-1263
European journal of preventive cardiology, 29(8), 1248-1263. SAGE Publications Ltd
European Journal of Preventive Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
This consensus document is proposed to clinicians to provide the whole spectrum of deep vein thrombosis management as an update to the 2017 consensus document. New data guiding clinicians in indicating extended anticoagulation, management of patients
Autor:
Andrea Fontanella, Giorgio Vescovo, Guy Meyer, Cecilia Becattini, Rupert Bauersachs, Caravaggio Study Investigators, Menno V. Huisman, Alexander T. Cohen, Adam Torbicki, Melina Verso, Mauro Campanini, Jean M. Connors, Maria R Sueiro, Andrés Muñoz, Catherine Lambert, Gualberto Gussoni, Giancarlo Agnelli, Benjamin Brenner
Publikováno v:
New England Journal of Medicine, 382(17), 1599-1607. MASSACHUSETTS MEDICAL SOC
The New England journal of medicine, Vol. 382, no.17, p. 1599-1607 (2020)
The New England journal of medicine, Vol. 382, no.17, p. 1599-1607 (2020)
BACKGROUND: Recent guidelines recommend consideration of the use of oral edoxaban or rivaroxaban for the treatment of venous thromboembolism in patients with cancer. However, the benefit of these oral agents is limited by the increased risk of bleedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d81ab8fee73383797d621f344c535c5
http://hdl.handle.net/1887/3184872
http://hdl.handle.net/1887/3184872
Autor:
Jan Beyer-Westendorf, Peter Verhamme, Anthony Maraveyas, Rupert Bauersachs, Jeffrey I. Weitz, Mark Crowther, Hanno Riess, Annie M. Young
Publikováno v:
Critical Reviews in Oncology/Hematology. 157:103125
Low-molecular-weight heparin (LMWH) therapy is recommended over vitamin K antagonists (VKAs) for the treatment of cancer-associated thrombosis (CAT) and extended therapy is recommended in those with active cancer to prevent recurrent thrombosis. Howe
Autor:
Hanno Riess, Ian Chau, Rupert Bauersachs, Cecilia Becattini, Marcos Renni, Anthony Maraveyas, Annie M. Young, Alexander T. Cohen, Cihan Ay, Jan Beyer‐Westendorf, Alok A. Khorana, Francis Cajfinger
Publikováno v:
The oncologist. 23(7)
Direct oral anticoagulants (DOACs) have proven efficacy and safety and are approved for use in the prevention and treatment of thromboembolic events in patients with venous thromboembolism (VTE) and those with atrial fibrillation (AF). There is no cl
Autor:
Rupert Bauersachs
Publikováno v:
Thrombosis research. 135
Background: Occurrence of venous thromboembolism (VTE) in patients with cancer is associated with unfavorable prognosis, and VTE treatment is less effective and more complicated in cancer patients. Several women specific aspects related to the underl
Autor:
Guy Meyer, Mette S. Janas, Pieter Willem Kamphuisen, Agnes Y.Y. Lee, Mikala F. Jarner, Rupert Bauersachs, Alok A. Khorana
Publikováno v:
BMC Cancer
BMC Cancer, 13(15):284. BMC
BMC Cancer, 13(15):284. BMC
Background: Low-molecular-weight heparin (LMWH) is recommended and commonly used for extended treatment of cancer-associated thrombosis (CAT), but its superiority over warfarin has been demonstrated in only one randomised study. We report here the ra
Autor:
Michael B. Streiff, M Beckers, Manuel Monreal, Mohammed H. Qari, Ajay K. Kakkar, Shaker A. Mousa, Barry M. Brenner, Rupert Bauersachs, Nissim Haim, Paolo Prandoni, Philippe Debourdeau, Anna Falanga, Martin H. Prins, Michel Marty, Alok A. Khorana, C. Baglin, Ingrid Pabinger, Konstantinos N. Syrigos, Dialina Brilhante, Mario Mandalà, Dominique Farge, Henri Bounameaux, Ramón Lecumberri, H. R. Büller, G T Gerotzafias, Simon Noble
Publikováno v:
Journal of Thrombosis and Haemostasis, Vol. 11, No 1 (2013) pp. 56-70
Journal of Thrombosis and Haemostasis, 11(1), 56-70. Wiley
Journal of Thrombosis and Haemostasis, 11(1), 56-70. Wiley
Summary. Background: Guidelines addressing the management of venous thromboembolism (VTE) in cancer patients are heterogeneous and their implementation has been suboptimal worldwide. Objectives: To establish a common international consensus addressin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2bf2d3717be38b9bf609b87eb0f91d
http://hdl.handle.net/11391/1480953
http://hdl.handle.net/11391/1480953
Autor:
Mette S. Janas, Agnes Y.Y. Lee, Guy Meyer, Alok A. Khorana, Rupert Bauersachs, Catch Investigators, Pieter Willem Kamphuisen, Mikala F. Jarner
Publikováno v:
Journal of Clinical Oncology. 33:9621-9621
9621 Background: Cancer patients with VTE continue to remain at high risk for recurrent VTE even with adequate anticoagulation. We determined baseline clinical predictors of recurrent VTE, includin...
Autor:
Rupert Bauersachs, Dialina Brilhante, G T Gerotzafias, Mario Mandalà, Simon Noble, Henri Bounameaux, Ramón Lecumberri, Anna Falanga, H. R. Büller, Michael B. Streiff, C. Baglin, Nissim Haim, Manuel Monreal, Alok A. Khorana, Michel Marty, Dominique Farge, Mohammed H. Qari, Shaker A. Mousa, Philippe Debourdeau, M Beckers, Ingrid Pabinger, Barry M. Brenner, Paolo Prandoni, Ajay K. Kakkar, Martin H. Prins, Konstantinos N. Syrigos
Publikováno v:
Journal of Thrombosis and Haemostasis, 11(1), 71-80. Wiley
Journal of thrombosis and haemostasis, 11(1), 71-80. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, Vol. 11, No 1 (2013) pp. 71-80
Journal of thrombosis and haemostasis, 11(1), 71-80. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, Vol. 11, No 1 (2013) pp. 71-80
Abstract 4357 Background Use of long term indwelling central venous catheter (CVC) is associated with symptomatic (Σ) events in up to 30% of cancer patients (pts), which may lead to pulmonary embolism (PE) and loss of the CVC. Lack of consensus on m